| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Calcipotriol/Betamethasone dipropionate |
| Brand | Enstilar® |
| Indication | For the topical treatment of psoriasis vulgaris in adults |
| Assessment Process | |
| Rapid review commissioned | 17/05/2016 |
| Rapid review completed | 21/06/2016 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |